4142:TPE
Adimmune Corp
NT$17.25
arrow_upward
+0.29%(+0.050) 1D
Jun 3, 10:41:29 AM GMT+8 · TWD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4142...
Open
NT$17.20
High
NT$17.30
Low
NT$17.05
Mkt. cap
7.41B
Avg. vol.
1.18M
Volume
652.20K
52-wk high
NT$22.50
52-wk low
NT$15.90
EPS
-NT$0.48
Shares outstanding
235.29M
No. of employees
564
Open
NT$17.20
High
NT$17.30
Low
NT$17.05
Mkt. cap
7.41B
Avg. vol.
1.18M
Volume
652.20K
52-wk high
NT$22.50
52-wk low
NT$15.90
EPS
-NT$0.48
Shares outstanding
235.29M
No. of employees
564
News stories
From sources across the web
Simply Wall Street
·
11 minutes ago
AGNC Investment’s 2b Equity Program Tests Valuation And Dividend Outlook
Yahoo Finance
·
1 hour ago
S&P 500, Nasdaq, Dow Futures Ease After Another Record Close As AI Momentum Cushions Iran's Expanding Strikes: MRVL, AVGO, MSFT, PANW In Focus
Simply Wall Street
·
1 hour ago
iRhythm Holders Back Governance Shift As Shares Trade Below Estimates
Forbes
·
5 hours ago
How This Stock Became The S&P 500’s Worst Performer Of The Year
Profile
Adimmune Corporation is a Taiwanese biopharmaceutical company headquartered in Taichung. Originally founded in 1965 as Taiwan’s first vaccine laboratory, it later evolved into a modern vaccine manufacturer and contract development and manufacturing organization. The company is notable for being the only influenza vaccine manufacturer in Asia certified by both the European Union Good Manufacturing Practice and the U.S. Food and Drug Administration, and the*only human vaccine manufacturer in Taiwan operating under PIC/S GMP standards. Wikipedia
About Adimmune Corp
AI content may include mistakes. Learn more